BACE1 and Alzheimer disease: Furthermore, Western blotting analysis also revealed a notable decrease in BACE1 protein levels in both hippocampus and cortex of AD mice treated with PPR@siBACE1, compared to the PBS, siBACE1, and PPR@siBACE1 treatment (Fig.7b, Fig. S15a).